Antimalarial activity of sera from subjects taking HIV protease inhibitors

AIDS

Volumn 21, Issue 6, 2007, Pages 763-765

  Redmond, Andrew M ^a   Skinner Adams, Tina ^b,c   Andrews, Katherine T ^c   Gardiner, Donald L ^c   Ray, John ^d   Kelly, Mark ^e   McCarthy, James S ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e Sexual Health and AIDS Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; LOPINAVIR PLUS RITONAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ANTIMALARIAL ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; GROWTH INHIBITION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; PARASITE CONTROL; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHLOROQUINE; DRUG SYNERGISM; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMIDINONES; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; SAQUINAVIR; TREATMENT OUTCOME;

EID: 34147106918     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328031f41a     Document Type: Article

References (14)

1. Mwapasa V, Rogerson SJ, Molyneux ME, Abrams ET, Kamwendo DD, Lema VM, et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 2004; 18:1051-1059.
2. Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS 2004; 18:547-554.
3. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356:1051-1056.
4. Van Eijk AM, Ayisi JG, ter Kuile FO, Misore AO, Otieno JA, Rosen DH, et al. HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS 2003; 17:595-603.
5. Ayisi JG, van Eijk AM, Newman RD, ter Kuile FO, Shi YP, Yang C, et al. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004; 10:643-652.
6. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Sewankambo N, Lutalo T, et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 2003; 17:2539-2541.
7. Inion I, Mwanyumba F, Gaillard P, Chohan V, Verhofstede C, Claeys P, et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 2003; 188:1675-1678.
8. Skinner-Adams TS, McCarthy JS, Gardiner DL, Hilton PM, Andrews KT. Antiretrovirals as antimalarial agents. J Infect Dis 2004; 190:1998-2000.
9. Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother 2005; 49:2983-2985.
10. Andrews KT, Fairlie DP, Madala PK, Ray J, Wyatt DM, Hilton PM, et al. Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother 2006; 50:639-648.
11. 50 in studies of drug resistance of malaria parasites. Acta Trop 1993; 55:257-261.
12. Kotecka BM, Rieckmann KH. Chloroquine bioassay using malaria microcultures. Am J Trop Med Hyg 1993; 49:460-464.
13. Andersen SL, Oloo AJ, Gordon DM, Ragama OB, Aleman GM, Berman JD, et al. Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clin Infect Dis 1998; 26:146-150.
14. Yeo AE, Edstein MD, Shanks GD, Rieckmann KH. Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro. Parasitol Res 1997; 83:489-491.